XML 49 R21.htm IDEA: XBRL DOCUMENT
v3.22.4

Stock Option and Grant Plan | 12 Months Ended
--- | ---
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract] |
Stock Option and Grant Plan | 13. Stock Option and Grant Plan Stock Incentive Plan—In January 2022, the Company’s board of directors adopted, and its stockholders approved the 2022 Stock Option and Incentive Plan, or 2022 Plan, which became effective on January 5, 2022, at which point no further grants would be made under the 2015 Stock Option and Restricted Stock Plan, or 2015 Plan. Under the 2022 Plan, the Company may grant incentive stock options, or ISOs, non-statutory stock options, stock appreciation rights, restricted stock units, restricted stock awards and other stock-based awards. As of December 31, 2022, there were 2,817,751 shares available for future issuance under the 2022 Plan. The options issued under the 2022 Plan expire 10 years following the date of grant. Stock options and restricted stock units typically vest over 4 years. We recognize the compensation cost of awards subject to service-based vesting conditions over the requisite service period, which is generally equal to the vesting period of the respective award. Initially, subject to adjustment as provided in the 2022 Plan, the aggregate number of shares of the Company’s common stock available for issuance under the 2022 Plan is 7,650,000. The number of shares of the Company’s common stock reserved for issuance under the 2022 Plan will automatically increase on January 1 of each year commencing January 1, 2023, by 5% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company’s board of directors. The maximum current number of shares that may be issued pursuant to the exercise of ISOs under the 2022 Plan is 7,650,000. The maximum number of shares of the Company’s common stock subject to awards granted under the 2022 Plan or otherwise during a single calendar year to any individual nonemployee director, taken together with any cash fees paid by the Company to such nonemployee director during the calendar year for serving on the Company’s board of directors, will not exceed $750,000 in total value, or, with respect to the calendar year in which a nonemployee director is first appointed or elected to the Company’s board of directors, $1,000,000. All options and awards granted under the 2015 Plan consisted of the Company’s common stock. As of January 6, 2022, no additional stock awards have been or will be granted under the 2015 Plan. Although the 2015 Plan was terminated as to future awards in January 2022, it continues to govern the terms of options that remain outstanding under the 2015 Plan. General Option Information The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:
|  | Year Ended December 31, |
|  | 2022 |  |  | 2021 |
Grant price |  | $ | 20.29 |  |  | $ | 7.69 |
Risk-free interest rate |  |  | 1.97 | % |  |  | 1.01 | %
Expected term (in years) |  |  | 6.07 |  |  |  | 5.73 |
Expected volatility |  |  | 88.75 | % |  |  | 81.61 | %
Dividend yield |  |  | 0.00 | % |  |  | 0.00 | %
The per share weighted average grant date fair value of stock options granted during the year ended December 31, 2022 and 2021 was $15.10 and $5.25, respectively. A summary of option activity for the year ended December 31, 2022, is as follows:
|  | Number of Options |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term (in years) |  |  | Aggregate Intrinsic Value (in thousands) |
Outstanding at December 31, 2021 |  |  | 5,339,011 |  |  | $ | 5.54 |  |  |  | 8.7 |  |  | $ | 15,627 |
Granted |  |  | 4,237,720 |  |  | $ | 20.29 |  |  |  |  |  |  |
Exercised |  |  | (950,013 | ) |  | $ | 2.33 |  |  |  |  |  |  |
Cancelled or forfeited |  |  | (145,768 | ) |  | $ | 10.98 |  |  |  |  |  |  |
Outstanding at December 31, 2022 |  |  | 8,480,950 |  |  | $ | 13.19 |  |  |  | 8.2 |  |  | $ | 201,765 |
Exercisable at December 31, 2022 |  |  | 2,055,416 |  |  | $ | 6.03 |  |  |  | 7.0 |  |  | $ | 63,408 |
Unvested at December 31, 2022 |  |  | 6,425,534 |  |  | $ | 15.47 |  |  |  | 8.6 |  |  | $ | 138,357 |
The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the options and the fair value of the Company’s common stock for those options that had exercise prices lower than the fair value of the Company’s common stock. The aggregate intrinsic value of options exercised during the years ended December 31, 2022 and 2021, was $14.2 million and $6.2 million, respectively. The total fair value of stock options vested during the years ended December 31, 2022 and 2021 was $8.8 million and $1.3 million, respectively. Restricted Stock Unit Activity A summary of restricted stock unit activity for the year ended December 31, 2022, is as follows:
|  | Number of shares |  |  | Weighted Average Grant Date Fair Value |
Nonvested as of December 31, 2021 |  |  | — |  |  | $ | — |
Granted |  |  | 752,613 |  |  | $ | 19.98 |
Vested |  |  | — |  |  | $ | — |
Forfeited |  |  | (12,316 | ) |  | $ | 17.82 |
Nonvested as of December 31, 2022 |  |  | 740,297 |  |  | $ | 20.02 |
Stock-Based Compensation Expense—The Company recorded stock-based compensation expense in the following expense categories of its statements of operations:
|  | Year Ended December 31, |
|  | 2022 |  |  | 2021 |
|  | (in thousands) |
Research and development expenses |  | $ | 5,639 |  |  | $ | 888 |
Selling, general and administrative expenses |  |  | 16,075 |  |  |  | 2,248 |
Total stock-based compensation |  | $ | 21,714 |  |  | $ | 3,136 |
The following table summarizes stock-based compensation by type of award:
|  | Year Ended December 31, |
|  | 2022 |  |  | 2021 |
|  | (in thousands) |
Stock options |  | $ | 18,844 |  |  | $ | 3,136 |
Restricted stock units |  |  | 2,870 |  |  |  | — |
Total stock-based compensation expense |  | $ | 21,714 |  |  | $ | 3,136 |
The following table summarizes unrecognized stock-based compensation expense as of December 31, 2022, by type of awards, and the weighted-average period over which that expense is expected to be recognized. The total unrecognized stock-based compensation expense will be adjusted for actual forfeitures as they occur.
|  | As of December 31, 2022 |
|  | Unrecognized Expense |  |  | Weighted-average Recognition Period |
|  | (in thousands) |  |  | (in years) |
Stock options |  | $ | 61,049 |  |  |  | 2.79 |
Restricted stock units |  | $ | 11,950 |  |  |  | 3.25 |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI https://asc.fasb.org/topic&trid=2228938 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (l) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration